Radionuclides are used in nuclear medicine for the diagnosis and therapeutic treatment of human diseases. These radionuclides are produced in the cyclotron or the reactor as discussed in Chapter 3. These facilities are available in only a few institutions, and only long-lived radionuclides can be supplied to distant institutions. The short-lived radionuclides cannot be shipped to the distant places because of their rapid decay.
KeywordsMethyl Ethyl Ketone Distant Institution Molybdenum Isotope Daughter Nuclide Daughter Activity
Unable to display preview. Download preview PDF.
- Boyd RE (1973) Recent developments in generators of 99mTc. In : Radiopharmaceuticals and labelled compounds, Vol 1. IAEA, Vienna, p 3Google Scholar
- Brucer M (1965) One hundred and eighteen radioisotope cows. Isot Radiat Technol 3: 1Google Scholar
- Richards P (1966) Nuclide generators. In: Radioactive pharmaceuticals, CONF-651111, US Atomic Energy Commission, Oak Ridge, p 155Google Scholar
- Richards P (1966) 99mTc Generators. In : Radioactive pharmaceuticals, CONF-651111, US Atomic Energy Commission, Oak Ridge, p 323Google Scholar
- Richards P, O’Brien MJ (1964) Rapid determination of 99Mo in separated 99mTc. J Nucl Med 10: 871Google Scholar
- Subramanian G, McAfee JG (1976) Radioisotope generators. In : Tubis M, Wolf W (eds) Radiopharmacy. Wiley, New York, p 255Google Scholar
- U.S. Pharmacopeia XIX. United States Pharmacopeial Convention, Rockville, Md, p 463 (1975)Google Scholar
- Yano Y, Anger HO (1964) A gallium-68 positron cow for medical use. J Nucl Med 5: 485Google Scholar